.jpg)
A Manx company has become the lead investor in a biotech company which is hoping to produce eat-yourself-thin foods.
Amphion Innovations has agreed a deal with American firm WellGen which has now received around £5 million in financing.
WellGen says the cash will be used to develop its line of nutraceuticals products, including an anti-obesity ingredient for use in functional foods.
It now plans to launch a human study of the ingredient’s effectiveness.
Island-based Strix factory to close
Retailer to stop selling 'untenable' newspapers and magazines
Hospitality boss says losing website address has 'massively' affected business
